Latest News
Boosting Science is a Good Investment
Congress still has an opportunity to meet the moment and make a once-in-a-generation investment in science and innovation with new funding that will bring major economic returns while bolstering our competitiveness in the international knowledge marketplace, write Dr. Gary K. Michelson and Sudip Parikh.
The Case for Supporting Early-Career Researchers to Prepare for Future Pandemics and Find Cures
Today is the International Day of Immunology, a global celebration of immunology and an opportunity to educate the general public about the important role immunologists play. The three recipients of the Michelson Philanthropies & Science Prize for Immunology presented their groundbreaking work in a recent virtual award ceremony.
Groundbreaking Early-Career Scientists Present Research Proposals During the 2021 Michelson Prizes Ceremony
The Michelson Medical Research Foundation and the Human Immunome Project awarded the 2021 Michelson Prizes to Dr. Camila Consiglio of Karolinska Institutet, Dr. Rong Ma of Emory University, and Dr. Nicholas Wu of the University of Illinois at Urbana-Champaign during a recent virtual ceremony hosted by Pulitzer Prize-winning journalist Laurie Garrett.
Finding Cures Faster: Bring the FDA into the 21st Century with Advanced Testing
If the FDA and a bipartisan group in Congress follow through on their promises, the animal testing requirement in medical research could be history, write Dr. Gary Michelson and Aysha Akhtar.
Dr. Scott Biering Investigates the Role of Viral Proteins
Dr. Scott Biering, a finalist for the Michelson Philanthropies & Science Prize wrote about a conserved flavivirus protein that holds potential as a target for versatile vaccines and therapies.
Dr. Lisa Wagar: Immune Reponses to Viruses and Vaccines
Dr. Lisa Wagar, a finalist for the Michelson Philanthropies & Science Prize, researches translational human immunology and the use of organoids to understand the complex interactions that occur between immune cells upon vaccination and infection in humans.
Inaugural Recipient of the Michelson Philanthropies & Science Prize for Immunology Explores Disparity of COVID Severity
On February 24, Michelson Philanthropies and AAAS/Science awarded Dr. Paul Bastard with the inaugural Michelson Philanthropies & Science Prize for Immunology, a $30,000 grant for transformative research in human immunology, for his work on COVID severity.
‘A Call to Action’: Dr. Peter Kuhn of USC Michelson Center Visits White House to Help Launch President Biden’s Cancer Moonshot Initiative
President Biden announced the relaunch of the Cancer Moonshot Initiative, which aims to reduce the cancer death rate in the United States by 50% over the next 25 years.
Dr. Rong Ma, 2021 Michelson Prizes Recipient
2021 Michelson Prize recipient Dr. Rong Ma says the award will serve as a catalyst to provide the freedom she needs to advance her research.
Dr. Camila Consiglio, 2021 Michelson Prizes Recipient
2021 Michelson Prize recipient Dr. Camila Consiglio says the award will advance her research into how sex hormones impact the immune system of Swedish citizens who are undergoing sex reassignment therapy over time.
Dr. Nicholas C. Wu, 2021 Michelson Prizes Recipient
2021 Michelson Prize recipient Dr. Nicholas Wu says the award will help advance his high-risk/high-reward research on the influenza virus.
2021 Michelson Prizes Push New Frontiers in Human Immunology
The Michelson Medical Research Foundation and the Human Immunome Project proudly recognize three outstanding early career researchers with the 2021 Michelson Prizes award: Dr. Camila Consiglio of Karolinska Institutet; Dr. Rong Ma of Emory University; and Dr. Nicholas Wu of the University of Illinois.
‘Push the Boundaries’: 2020 Michelson Prize Winners on How the Award Advanced Their High-Risk/High-Reward Research
As the Michelson Medical Research Foundation and the Human Immunome Project (HIP) gear up to announce the latest winners of the 2021 Michelson Prizes on January 25, the 2020 winners discuss how receiving the prize has been instrumental in advancing their groundbreaking research at the dawn of their careers.
‘Think Big’: 2019 Michelson Prize Winners on How the Award Advanced Their High-Risk/High-Reward Research
As the Michelson Medical Research Foundation and the Human Immunome Project (HIP) gear up to announce the latest winners of the 2021 Michelson Prizes on January 25, the 2019 winners discuss how receiving the prize has been instrumental in advancing their groundbreaking research at the dawn of their careers.
‘Science Driven by Passion’: 2018 Michelson Prize Winners on How the Award Advanced Their High-Risk/High-Reward Research
As the Michelson Medical Research Foundation and the Human Immunome Project gear up to announce the latest winners of the 2021 Michelson Prizes on January 25, the 2018 winners discuss how receiving the prize has been instrumental in advancing their groundbreaking research at the dawn of their careers.
Dr. Michelson Advocates for Establishing a “National Institute for Cures” to Fast-Track Drug and Vaccine Development
Dr. Gary Michelson makes the case for why increased fast tracking of funding and development for innovative scientific developments is key for our future in the latest COVID-19 edition of National Academy of Inventors’ Technology & Innovation Journal.
Young and Diverse Teams of Researchers Produce More Impactful Science
Diversity of thought and experience is critical to science and the scientific method, said Dr. Ansuman Satpathy of Stanford in a recent Science podcast sponsored by Michelson Philanthropies.
A Conversation With Dr. Laura Mackay | Science Podcast
Dr. Laura Mackay, professor and laboratory head of the Peter Doherty Institute at the University of Melbourne, discusses the importance of supporting and promoting diversity in STEM with Science editor Sean Sanders, PhD.
Applications Now Open for the Michelson Philanthropies & Science Prize for Immunology
Early-career researchers can apply for the Michelson Philanthropies & Science Prize for Human Immunology from May 15 to October 1, 2021.
